Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Med Life with Dr. Horton
    • Podcasts
    • Videos
    • Alerts
    • RSS
    • Classified ads
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Activate online account
    • Look up login
    • Earn CPD Credits
    • Members Corner
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
    • Activate subscription
    • Look up login
    • Manage account
    • Manage IPs
    • View Reports
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JPN

User menu

  • Subscribe
  • My alerts
  • My Cart
  • Log in

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JPN
  • Subscribe
  • My alerts
  • My Cart
  • Log in
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Med Life with Dr. Horton
    • Podcasts
    • Videos
    • Alerts
    • RSS
    • Classified ads
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Activate online account
    • Look up login
    • Earn CPD Credits
    • Members Corner
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
    • Activate subscription
    • Look up login
    • Manage account
    • Manage IPs
    • View Reports
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Letters

A national drug agency

Roy West, E. Keith Borden, Jean-Paul Collet, Nigel S.B. Rawson and Robert S. Tonks
CMAJ April 15, 2003 168 (8) 962-963;
Roy West
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. Keith Borden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Paul Collet
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nigel S.B. Rawson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert S. Tonks
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

Like the editors of CMAJ,1 we strongly support the Romanow Commission's recommendation for a national drug agency.2 Our recent study3 showed that the current system of listing drugs for reimbursement on the basis of estimates of how well they will work in routine medical practice is seriously flawed. We found considerable differences between provinces in their drug review processes. Furthermore, reviewers were making decisions (to list or not list new drugs in their formularies) without having the information they considered “necessary” for such decisions. Probably in direct relation to these 2 factors, we identified wide differences between provinces regarding drug acceptances and refusals. We also found that not all provinces have the resources to do adequate evaluations of new drugs.

There is a need to replace the present flawed system with a national drug agency that would evaluate premarketing data and, eventually, postmarketing use of new drugs, according to scientifically appropriate methods and documented policies and procedures.3

With the agreement of federal and provincial ministers of health, the Canadian Coordinating Office on Health Technology Assessment is setting up a Common Drug Review initiative4 to carry out such evaluations of new drugs. But is this the best choice for developing and overseeing this extremely important function? The placement and oversight of a national drug agency needs to be debated now.

We believe that a national drug agency must be publicly responsible, free-standing, credible and capable of attracting an expert leader in this highly specialized assessment field.

Roy West Professor Memorial University of Newfoundland St. John's, Nfld. E. Keith Borden Pharmacoepidemiology Consultant Toronto, Ont. Jean-Paul Collet Associate Professor McGill University Montréal, Que. Nigel S.B. Rawson Senior Researcher Center for Health Care Policy and Evaluation Minneapolis, Minn. Robert S. Tonks Professor Dalhousie University Halifax, NS

References

  1. 1.↵
    We need Romanow's National Drug Agency [editorial]. CMAJ 2003;168(3):249.
    OpenUrlFREE Full Text
  2. 2.↵
    Romanow RJ. Building on values: the future of health care in Canada. Ottawa: Commission on the Future of Health Care in Canada; 2002. Available at: www.healthcarecommission.ca (accessed 2003 Jan 28).
  3. 3.↵
    West R, Borden EK, Collet JP, Rawson NSB, Tonks RS. “Cost-effectiveness” estimates result in flawed decision-making in listing drugs for reimbursement. Can J Public Health 2002;93:421-5.
    OpenUrlPubMed
  4. 4.↵
    An introduction to the Common Drug Review (CDR). Ottawa: Canadian Coordinating Office for Health Technology Assessment; 2002. Available at: www.ccohta.ca/entry_e.html (accessed 2003 Feb 5).
PreviousNext
Back to top

In this issue

CMAJ
Vol. 168, Issue 8
15 Apr 2003
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A national drug agency
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
Citation Tools
A national drug agency
Roy West, E. Keith Borden, Jean-Paul Collet, Nigel S.B. Rawson, Robert S. Tonks
CMAJ Apr 2003, 168 (8) 962-963;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
A national drug agency
Roy West, E. Keith Borden, Jean-Paul Collet, Nigel S.B. Rawson, Robert S. Tonks
CMAJ Apr 2003, 168 (8) 962-963;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • Scopus
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Avoiding harm to patients: properly calculating costs of harm
  • Continuity of care: the key in telemedicine
  • Open secret: Time of day matters in clinical practice
Show more Letters

Similar Articles

Collections

  • Topics
    • Health policy
    • Health care coverage
    • Canadian government

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Videos
  • Alerts
  • RSS

Information for

  • Advertisers
  • Authors
  • CMA Members
  • Copyright and Permissions
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact

Copyright 2019, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

Powered by HighWire